Literature DB >> 15608664

Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells.

Priscilla Soulié1, Fabio Carrozzino, Michael S Pepper, Alex Y Strongin, Marie-France Poupon, Roberto Montesano.   

Abstract

Overexpression of membrane-type-1 matrix metalloproteinase (MT1-MMP) in tumor cells has previously been shown to enhance tumor growth and metastasis. To establish if MT1-MMP is also able to confer tumorigenicity on nonmalignant epithelial cells, we transfected human MT1-MMP cDNA into Madin-Darby canine kidney (MDCK) cells expressing a tetracycline-repressible transactivator. Induction of MT1-MMP in the absence of doxycycline (Dox) was associated with activation of exogenous MMP-2 as well as with formation of large cysts and increased invasiveness in collagen matrices. Transfected cells were inoculated subcutaneously into two groups of nude mice, one of which received Dox to inhibit expression of MT1-MMP. Formation of tumor xenografts was observed in 11 of 17 mice maintained without Dox, but only in two of nine mice that received Dox (P<0.05). The xenografts were composed of tubular structures interspersed within a highly cellular stroma. The epithelial cells delimiting the lumen were polarized, as indicated by the basolateral distribution of Na,K-ATPase. Despite their differentiated appearance, the tumors lacked a well-defined boundary, and epithelial tubules invaded adjacent muscular layers. These results demonstrate that conditional expression of MT1-MMP in nonmalignant MDCK epithelial cells is by itself sufficient to drive formation of invasive tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608664     DOI: 10.1038/sj.onc.1208360

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo.

Authors:  Vladislav S Golubkov; Andrei V Chernov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen.

Authors:  Patricia A Eisenach; Pedro Corrêa de Sampaio; Gillian Murphy; Christian Roghi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.

Authors:  Oğuzhan Karaosmanoğlu; Sreeparna Banerjee; Hülya Sivas
Journal:  Cell Oncol (Dordr)       Date:  2018-06-01       Impact factor: 6.730

4.  Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.

Authors:  Rajeev Mahimkar; Maria Alejandra Alfonso-Jaume; Leslie M Cape; Rajvir Dahiya; David H Lovett
Journal:  Carcinogenesis       Date:  2011-09-28       Impact factor: 4.944

5.  MT1-MMP cooperates with Kras(G12D) to promote pancreatic fibrosis through increased TGF-β signaling.

Authors:  Seth B Krantz; Mario A Shields; Surabhi Dangi-Garimella; Eric C Cheon; Morgan R Barron; Rosa F Hwang; M Sambasiva Rao; Paul J Grippo; David J Bentrem; Hidayatullah G Munshi
Journal:  Mol Cancer Res       Date:  2011-08-19       Impact factor: 5.852

6.  Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2.

Authors:  Surabhi Dangi-Garimella; Seth B Krantz; Morgan R Barron; Mario A Shields; Michael J Heiferman; Paul J Grippo; David J Bentrem; Hidayatullah G Munshi
Journal:  Cancer Res       Date:  2010-12-08       Impact factor: 12.701

7.  Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes.

Authors:  Surabhi Dangi-Garimella; Amanda J Redig; Mario A Shields; Mohammed A Siddiqui; Hidayatullah G Munshi
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

Review 8.  Tumour endoproteases: the cutting edge of cancer drug delivery?

Authors:  J M Atkinson; C S Siller; J H Gill
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

9.  Induction of Smad1 by MT1-MMP contributes to tumor growth.

Authors:  Jaclyn A Freudenberg; Wen-Tien Chen
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

Review 10.  Deciphering the molecular basis of breast cancer metastasis with mouse models.

Authors:  Ann E Vernon; Suzanne J Bakewell; Lewis A Chodosh
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.